Login to Your Account



Pharma: Other News To Note


Tuesday, August 28, 2012

• Merz Inc., of Greensboro, N.C., said it acquired Cuvposa (glycopyrrolate) oral solution, an acetylcholine receptor inhibitor, for pediatric chronic severe drooling associated with neurologic conditions such as cerebral palsy. Financial terms were not disclosed.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription